Evidence map›Paper›PMID 34167520›Full record

Observational studyCardiovascular diabetology2021

Relationship between diabetes mellitus and atrial fibrillation prevalence in the Polish population: a report from the Non-invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) prospective cross-sectional observational study.

Jakub Gumprecht, Gregory Y H Lip, Adam Sokal, Beata Średniawa, Katarzyna Mitręga, Jakub Stokwiszewski, Łukasz Wierucki, Aleksandra Rajca, Marcin Rutkowski, Tomasz Zdrojewski and 4 more

Registry-linked trialOpen access · goldAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Cardiovascular diabetology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03243474 (Non-invasive Monitoring for Early Detection of Atrial Fibrillation), which is not on this map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03243474 completednot on this map

Non-invasive Monitoring for Early Detection of Atrial Fibrillation

TypeobservationalSponsorKardio-Med SilesiaRan2017 to 2019Enrolled3,014ConditionsAtrial Fibrillation
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Observational
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Observational
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 3 countries.

Jakub GumprechtLiverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, UK. kubagumprecht@gmail.com.ORCID 0000-0002-0575-9150
Gregory Y H LipLiverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, UK.
Adam SokalDepartment of Cardiology, Silesian Centre for Heart Diseases, Zabrze, Poland.
Beata ŚredniawaDMS in Zabrze, Department of Cardiology, Medical University of Silesia, Katowice, Poland.
Katarzyna MitręgaDepartment of Cardiology, Silesian Centre for Heart Diseases, Zabrze, Poland.
Jakub StokwiszewskiNational Institute of Hygiene, Warsaw, Poland.
Łukasz WieruckiDepartment of Preventive Medicine and Education, Medical University of Gdansk, Gdańsk, Poland.
Aleksandra RajcaDepartment of Preventive Medicine and Education, Medical University of Gdansk, Gdańsk, Poland.
Marcin RutkowskiDepartment of Preventive Medicine and Education, Medical University of Gdansk, Gdańsk, Poland.
Tomasz ZdrojewskiDepartment of Preventive Medicine and Education, Medical University of Gdansk, Gdańsk, Poland.
Tomasz GrodzickiDepartment of Internal Medicine and Gerontology, Jagiellonian University Medical College, Kraków, Poland.
Jarosław KaźmierczakDepartment of Cardiology, Pomeranian Medical University, Szczecin, Poland.
Grzegorz OpolskiFirst Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
Zbigniew KalarusDMS in Zabrze, Department of Cardiology, Medical University of Silesia, Katowice, Poland.
Gdańsk Medical University · PLMedical University of Silesia · PLSilesian Center for Heart Disease · PLUniversity of Liverpool · GBJagiellonian University · PLMedical University of Warsaw · PLNarodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy · PLPomeranian Medical University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe global burden of atrial fibrillation (AF) and diabetes mellitus (DM) is constantly rising, leading to an increasing healthcare burden of stroke. AF often remains undiagnosed due to the occurrence in an asymptomatic, silent form, i.e., silent AF (SAF). The study aims to evaluate the relationships between DM and AF prevalence using a mobile long-term continuous ECG telemonitoring vest in a representative Polish and European population ≥ 65 years for detection of AF, symptomatic or silent.

methodsA representative sample of 3014 participants from the cross-sectional NOMED-AF study was enrolled in the analyses (mean age 77.5, 49.1% female): 881 (29.2%) were diagnosed with DM. AF was screened using a telemonitoring vest for a mean of 21.9 ± 9.1days.

resultsOverall, AF was reported in 680 (22.6%) of the whole study population. AF prevalence was higher among subjects with concomitant DM (DM+) versus those without DM (DM-) [25%, 95% CI 22.5-27.8% vs 17%; 95% CI 15.4-18.5% respectively, p < 0.001]. DM patients were commonly associated with SAF [9%; 95% CI 7.9-11.4 vs 7%; 95% CI 5.6-7.5 respectively, p < 0.001], and persistent/permanent AF [12.2%; 95% CI 10.3-14.3 vs 6.9%; 95% CI 5.9-8.1 respectively, p < 0.001] compared to subjects without DM. The prolonged screening was associated with a higher percentage of newly established AF diagnosis in DM+ vs DM- patients (5% vs 4.5% respectively, p < 0.001). In addition to shared risk factors, DM+ subjects were associated with different AF and SAF independent risk factors compared to DM- individuals, including thyroid disease, peripheral/systemic thromboembolism, hypertension, physical activity and prior percutaneous coronary intervention/coronary artery bypass graft surgery.

conclusionsAF affects 1 out of 4 subjects with concomitant DM. The higher prevalence of AF and SAF among DM subjects than those without DM highlights the necessity of active AF screening specific AF risk factors assessment amongst the diabetic population.

trial registrationNCT03243474.

Indexed as

AgedAged, 80 and overAsymptomatic DiseasesAtrial FibrillationComorbidityCross-Sectional StudiesDiabetes MellitusEarly DiagnosisElectrocardiography, AmbulatoryFemaleHumansMalePolandPredictive Value of TestsPrevalenceProspective StudiesAtrial fibrillationDiabetes mellitusEpidemiologyLong-term monitoringPrevalence

Identifiers

PMID34167520
PMCPMC8228888
OpenAlexW3157341559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.